IL110530A - History of estradiol converted to 51,51 dialkyl and pharmaceutical preparations containing them - Google Patents

History of estradiol converted to 51,51 dialkyl and pharmaceutical preparations containing them

Info

Publication number
IL110530A
IL110530A IL11053094A IL11053094A IL110530A IL 110530 A IL110530 A IL 110530A IL 11053094 A IL11053094 A IL 11053094A IL 11053094 A IL11053094 A IL 11053094A IL 110530 A IL110530 A IL 110530A
Authority
IL
Israel
Prior art keywords
carbon atoms
compound
chain alkyl
mmol
estra
Prior art date
Application number
IL11053094A
Other languages
English (en)
Hebrew (he)
Other versions
IL110530A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL110530A0 publication Critical patent/IL110530A0/xx
Publication of IL110530A publication Critical patent/IL110530A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11053094A 1993-08-02 1994-08-01 History of estradiol converted to 51,51 dialkyl and pharmaceutical preparations containing them IL110530A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4326240A DE4326240A1 (de) 1993-08-02 1993-08-02 15,15-Dialkyl-substituierte Derivate des Estradiols

Publications (2)

Publication Number Publication Date
IL110530A0 IL110530A0 (en) 1994-11-11
IL110530A true IL110530A (en) 1998-08-16

Family

ID=6494482

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11053094A IL110530A (en) 1993-08-02 1994-08-01 History of estradiol converted to 51,51 dialkyl and pharmaceutical preparations containing them

Country Status (21)

Country Link
US (2) US5587496A (ru)
EP (1) EP0712412B1 (ru)
JP (1) JPH09500891A (ru)
KR (1) KR960703940A (ru)
CN (1) CN1040329C (ru)
AT (1) ATE175418T1 (ru)
AU (1) AU674609B2 (ru)
CA (1) CA2168657A1 (ru)
CZ (1) CZ26796A3 (ru)
DE (2) DE4326240A1 (ru)
FI (1) FI960465A (ru)
HU (1) HUT73238A (ru)
IL (1) IL110530A (ru)
MY (1) MY111121A (ru)
NO (1) NO960425L (ru)
NZ (1) NZ271091A (ru)
PL (1) PL312792A1 (ru)
RU (1) RU2147306C1 (ru)
SK (1) SK13596A3 (ru)
WO (1) WO1995004070A1 (ru)
ZA (1) ZA945754B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
DE10151365A1 (de) * 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
PT1748756E (pt) * 2004-03-10 2009-07-20 Bayer Schering Pharma Ag Composições compreendendo drospirenona molecularmente dispersa
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2275752A (en) * 1938-11-25 1942-03-10 Ciba Pharm Prod Inc Cyclic condensation products and process of making same
US3472881A (en) * 1965-05-14 1969-10-14 Merck & Co Inc 3 - hydroxy - 13 - lower alkyl - 15 - carboxyl - 1,3,5(10),8,14 - gonapentaen - 17-ones and intermediates in the production thereof
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DD145919B1 (de) * 1978-06-28 1982-06-30 Kurt Ponsold Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
DE69415812T2 (de) 1999-09-16
ZA945754B (en) 1995-03-15
MY111121A (en) 1999-08-30
US5587496A (en) 1996-12-24
NO960425L (no) 1996-04-02
US5656622A (en) 1997-08-12
HUT73238A (en) 1996-07-29
FI960465A0 (fi) 1996-02-01
AU7461094A (en) 1995-02-28
CN1128031A (zh) 1996-07-31
AU674609B2 (en) 1997-01-02
DE4326240A1 (de) 1995-02-09
RU2147306C1 (ru) 2000-04-10
PL312792A1 (en) 1996-05-13
CA2168657A1 (en) 1995-02-09
CN1040329C (zh) 1998-10-21
KR960703940A (ko) 1996-08-31
NO960425D0 (no) 1996-02-01
HU9600234D0 (en) 1996-04-29
EP0712412B1 (en) 1999-01-07
SK13596A3 (en) 1997-03-05
FI960465A (fi) 1996-02-01
NZ271091A (en) 1996-08-27
WO1995004070A1 (en) 1995-02-09
ATE175418T1 (de) 1999-01-15
JPH09500891A (ja) 1997-01-28
EP0712412A1 (en) 1996-05-22
CZ26796A3 (en) 1996-07-17
IL110530A0 (en) 1994-11-11
DE69415812D1 (de) 1999-03-18

Similar Documents

Publication Publication Date Title
EP1272504B1 (de) 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene
DE19706061A1 (de) Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
EP0712412B1 (en) 15,15-dialkyl-substituted derivatives of estradiol
US5502046A (en) 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents
CZ2002831A3 (cs) Nearomatické estrogenní steroidy
JPH0515720B2 (ru)
US5529993A (en) 14α, 17α-ethano-16α-hydroxy-estratrienes
US5418227A (en) 14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienes
US3654321A (en) 17alpha-methylenecyclopropyl- and 17alpha-spiropentyl steroids and process
JPH06506678A (ja) 14α,16α−エタノ−及び14α,16α−エテノ−エストラトリエン

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees